Boussard & Gavaudan Investment Management’s SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an SCPE.WS Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SCPE.WS Stock Details SCPE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300,000	Closed	-$618K	–	157
2021 Q2	$618K	Hold	300,000	–	–	0.06%	55
2021 Q1	$570K	Hold	300,000	–	–	0.06%	64
2020 Q4	$396K	Hold	300,000	–	–	0.06%	56
2020 Q3	$372K	Hold	300,000	–	–	0.05%	45
2020 Q2	$321	Buy	+300,000	New	+$306K	0.06%	34

Boussard & Gavaudan Investment Management's SCPE.WS Position: Q3 2021 in Review

Boussard & Gavaudan Investment Management sold out of SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an (SCPE.WS) in Q3 2021, closing a stake of 300,000 shares — an estimated $618K sold.

Boussard & Gavaudan Investment Management first reported a position in SCPE.WS in Q2 2020 and held it in 5 quarters. The position peaked at $618K in Q2 2021. 0 funds tracked by Wall St. Rank hold SCPE.WS as of Q3 2021.

Boussard & Gavaudan Investment Management reported no remaining SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position as of Q3 2021 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 300,000 SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an shares in Q3 2021, an estimated $618K.
Boussard & Gavaudan Investment Management first reported a position in SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an in Q2 2020 and held it in 5 quarters.
Boussard & Gavaudan Investment Management's SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position peaked at $618K in Q2 2021.
0 funds tracked by Wall St. Rank held SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an as of Q3 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.